{"id":111640,"date":"2025-12-19T23:54:08","date_gmt":"2025-12-19T23:54:08","guid":{"rendered":"https:\/\/www.europesays.com\/se\/111640\/"},"modified":"2025-12-19T23:54:08","modified_gmt":"2025-12-19T23:54:08","slug":"nio-lakemedelsjattar-till-sluter-avtal-om-sankta-priser","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/se\/111640\/","title":{"rendered":"Nio l\u00e4kemedelsj\u00e4ttar till sluter avtal om s\u00e4nkta priser"},"content":{"rendered":"<p>Ytterligare nio internationella l\u00e4kemedelsj\u00e4ttar har ing\u00e5tt avtal med USA om att s\u00e4nka priserna, s\u00e4ger Trump vid en presstr\u00e4ff i Vita huset.<\/p>\n<p>\u2013 De amerikanska l\u00e4kemedelspriserna kommer att falla rasande snabbt och snart ligga bland de l\u00e4gsta i den utvecklade v\u00e4rlden, s\u00e4ger Trump.<\/p>\n<p>Det handlar om Merck, Amgen, Roche, Novartis, Bristol-Myers Squibb, Gilead, Boehringer Ingelheim, GSK och Sanofi.<\/p>\n<p>Det betyder att 14 av de 17 bolag som Trump kontaktade i juli f\u00f6r att skriva avtal nu har skrivit p\u00e5. De som saknas \u00e4r Abbvie, Johnson &amp; Johnson och Regeneron. Och enligt handelsminister Howard Lutnick kommer de tre sista bolagens uppg\u00f6relser att presenteras inom kort.<\/p>\n<p>Omni \u00e4r politiskt obundna och oberoende. Vi str\u00e4var efter att ge fler perspektiv p\u00e5 nyheterna. Har du fr\u00e5gor eller synpunkter kring v\u00e5r rapportering? <a href=\"https:\/\/omni.se\/trump-ytterligare-nio-lakemedelsbolag-sanker-priserna\/a\/mailto:redaktion@omni.se\" class=\"ArticleActions_contactLink__W2F1M\" rel=\"nofollow noopener\" target=\"_blank\">Kontakta redaktionen<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"Ytterligare nio internationella l\u00e4kemedelsj\u00e4ttar har ing\u00e5tt avtal med USA om att s\u00e4nka priserna, s\u00e4ger Trump vid en presstr\u00e4ff&hellip;\n","protected":false},"author":2,"featured_media":111641,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[65],"tags":[12306,12303,12305,72,70,71,12304,12308,12301,12307,12302,34,31,33,32,30],"class_list":["post-111640","post","type-post","status-publish","format-standard","has-post-thumbnail","category-ekonomi","tag-abbvie","tag-amgen","tag-bristol-myers-squibb","tag-business","tag-economy","tag-ekonomi","tag-howard-lutnick","tag-merck","tag-novartis","tag-roche","tag-sanofi","tag-se","tag-svenska","tag-sverige","tag-sweden","tag-swedish"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@se\/115748933681836925","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts\/111640","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/comments?post=111640"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts\/111640\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/media\/111641"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/media?parent=111640"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/categories?post=111640"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/tags?post=111640"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}